Evidence map›Paper›PMID 19888579›Full record

ArticleRheumatology international2010

IL-23 and IL-17 in ankylosing spondylitis.

Daniel Wendling

Open access · bronzeAbstract readCommentLetter
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Secukinumab for ankylosing spondylitis and psoriatic arthritis.Therapeutics and clinical risk management · 2016
    Review
  4. Review
  5. Article
  6. Uveitis in seronegative arthritis.Current rheumatology reports · 2012
    Review
  7. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Daniel Wendling
University Teaching Hospital · ZM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, BlockingAntibodies, MonoclonalHumansInterleukin-23 Subunit p19Receptors, Interleukin-17Spondylitis, AnkylosingAntibodies, BlockingAntibodies, MonoclonalIL17RA protein, humanInterleukin-23 Subunit p19Receptors, Interleukin-17

Identifiers

PMID19888579
OpenAlexW2022657961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.